Investigating how certain lipids affect bacterial infections
Roles of novel cationic lipids in bacterial pathogenesis
This study is looking at how certain new lipids in the membranes of Gram-positive bacteria affect their survival and how they interact with our bodies, especially in relation to serious conditions like meningitis, with the hope of finding new ways to treat bacterial infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-11083692 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of novel cationic lipids in the membranes of Gram-positive bacteria, particularly how they influence bacterial survival and interactions with the human host. The study aims to explore how these lipids can disrupt the blood-brain barrier, which is crucial for understanding bacterial pathogenesis in diseases like meningitis. By examining the mechanisms of barrier disruption and the role of bacterial membrane vesicles, the research seeks to fill significant knowledge gaps in how these pathogens operate. Patients may benefit from insights gained that could lead to new therapeutic strategies against bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for infections caused by Gram-positive bacteria, particularly those susceptible to meningitis.
Not a fit: Patients with infections caused by Gram-negative bacteria or those not at risk for bacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent bacterial infections from breaching the blood-brain barrier, potentially reducing the incidence of meningitis and other serious conditions.
How similar studies have performed: While the specific approach of investigating cationic lipids in this context is novel, similar studies have shown promise in understanding bacterial pathogenesis and developing antimicrobial strategies.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Palmer, Kelli Lea — University of Texas Dallas
- Study coordinator: Palmer, Kelli Lea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.